市場調査レポート

商品コード

1363365

プロテイナーゼKの市場規模、シェア、動向分析レポート：形態別、治療領域別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

Proteinase K Market Size, Share & Trends Analysis Report By Form (Powder, Liquid), By Therapeutic Area (Infectious Diseases, Neurology, Oncology, Cardiology), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日: 2023年09月28日 | 発行: Grand View Research

| ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

Unprintable PDF (Single User License)

USD 5,950 932,722円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストはできません。PDFの印刷もできません。

Printable PDF (5-User License)

USD 6,950 1,089,482円

レポートPDFを同一企業内の同一部署における5名様までの方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

Printable PDF (Enterprise License)

USD 8,950 1,403,002円

レポートPDFの購入企業、およびその子会社、関連会社の方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

プロテイナーゼK市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、プロテイナーゼKの世界市場規模は2030年までに78億米ドルに達し、予測期間中のCAGRは8.7％を記録すると予測されています。

市場成長の原動力となっているのは、分子診断技術とそれに関連する体外診断用酵素の幅広い用途です。プロテイナーゼKはPCRやNGSの補助剤として利用できます。遺伝子発現プロファイリングとqPCRによる標的パネルが、病理検査室におけるNGSシーケンスの最も頻繁な用途であることに変わりはないです。さらに、NGSシーケンスの価格低下により、NSC技術の利用が拡大しています。したがって、NGS診断技術に対する需要の高まりが市場成長を後押しすると予想されます。

さらに、細胞分離手順の採用が増加していることも、市場成長に寄与する主な要因の1つです。企業は市場での競争力を得るために持続可能な技術の構築に着手しています。例えば、2022年4月、Levitas Bio社は既存の細胞分離用プラットフォームの次世代版を発表しました。新バージョンは、研究者の実験を最大16倍まで拡大し、1回あたり約4,000万個の細胞を処理することを支援するものと期待されています。

さらに、POCベースの診断薬の使用は世界的に著しく増加しています。感染症の症状やその予防法を特定することを目的とした一般市民の意識向上キャンペーンは、病気の伝播をコントロールする上で重要な役割を果たしています。このように、患者の関心の高まりがPOCの需要増につながっています。例えば、2020年5月、Specific High Sensitivity Enzymatic Reporter UnLOCKing（SHERLOCK）診断法によるCOVID-19のPOC検査に関する研究が発表されました。このように、POC診断に対する需要の高まりとPOC診断検査におけるプロテイナーゼKの有用性は、市場の成長を促進すると予想されます。

さらに、分子生物学やその他の分野でのプロテイナーゼKの用途拡大が、近い将来に有利な機会を生み出すと期待されています。プロテイナーゼKは、食品・飲食品業界で品質基準を維持するために使用されています。食品メーカーは、製造に使用する原材料の品質維持に努めています。さらに、プロテイナーゼKは加工食品からDNAを抽出する際の細胞溶解にも使用されます。この酵素はまた、幅広い分子生物学的アッセイにも応用されています。したがって、プロテイナーゼKのこのような用途は、予測期間中に市場を牽引すると予想されます。

プロテイナーゼK市場のハイライト

形態別では、粉末セグメントが2022年に圧倒的なシェアを占めました。粉末の利点には、保存期間が長い、出荷が安価、安定性が高いなどがあります。このような利点により、粉末の採用が増加すると予想されます。
治療分野別では、感染症分野が2022年に最大のシェアを獲得しました。低・中所得国での感染症罹患率の増加とともに、迅速分子検査におけるプロテイナーゼKの存在が、低資源環境でも操作しやすい製品の開発を促すと予想されます。これが市場の成長を加速させています。
用途別では、ゲノムDNAとRNAの分離・精製分野が2022年に最大のシェアを占めました。がんや希少疾患における個別化治療のニーズが高まる中、DNAやRNAの単離に対する需要は増加傾向にあり、同様の動向は市場にも反映されると予想されます。
最終用途別では、バイオテクノロジー企業が2022年に主要な収益シェアを占めました。これは、バイオテクノロジー企業の臨床研究および前臨床研究をサポートするためのインサイチュハイブリダイゼーション（ISH）技術の応用の増加によるものです。
北米は2022年に最大の市場シェアを占め、同地域におけるプロテイナーゼKの高い需要と感染症の流行増加により、予測期間中もリードを維持すると予測されています。
アジア太平洋は、ゲノミクス研究を促進するための様々な政府のイニシアチブと相まって、シーケンス技術のアプリケーションの増加により、将来的に大幅に成長すると予測されています。

市場系統の見通し
- 親市場の見通し
- 関連/付随市場の見通し
普及と成長の見通しマッピング
市場力学
- 市場促進要因の分析
- 市場抑制要因分析
プロテイナーゼK市場分析ツール
- 業界分析- ポーターのファイブフォース分析
- PESTEL分析

第4章プロテイナーゼK：形態別推定・動向分析

プロテイナーゼK市場：重要なポイント
プロテイナーゼK市場：動向と市場シェア分析、2022年および2030年
粉末
液体

第5章プロテイナーゼK：治療領域別推定・動向分析

プロテイナーゼK市場：重要なポイント
プロテイナーゼK市場：動向と市場シェア分析、2022年および2030年
感染症
糖尿病
腫瘍学
心臓病学
腎臓学
自己免疫疾患
神経内科
その他

第6章プロテイナーゼK：最終用途別推定・動向分析

プロテイナーゼK市場：重要なポイント
プロテイナーゼK市場：動向と市場シェア分析、2022年および2030年
ゲノムDNAおよびRNAの分離と精製
In situハイブリダイゼーション
ミトコンドリアの分離

第7章プロテイナーゼK：用途別推定・動向分析

プロテイナーゼK市場：重要なポイント
プロテイナーゼK市場：動向と市場シェア分析、2022年および2030年
受託研究機構
学術機関
バイオテクノロジー企業
診断ラボ

第8章プロテイナーゼK市場：地域別推定・動向分析

地域別の見通し
地域別のプロテイナーゼK市場：重要なポイント
北米
- 市場推計・予測、2018～2030年
- 米国
- カナダ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- デンマーク
- スウェーデン
- ノルウェー
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- タイ
- 韓国
ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- クウェート

第9章競合情勢

主要市場参入企業による最近の動向と影響分析
市場参入企業の分類
- Merck KGaA
- QIAGEN
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd
- Abcam plc.
- Agilent Technologies, Inc.
- Biocatalysts
- Minerva Biolabs GmbH
- Promega Corporation
- Takara Bio Inc.
- New England Biolabs
- MP BIOMEDICALS.

図表

List of Tables

Table 1 List of Abbreviation
Table 2 North America proteinase K market, by form, 2018 - 2030 (USD Million)
Table 3 North America proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 4 North America proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 5 North America proteinase K market, by application, 2018 - 2030 (USD Million)
Table 6 North America proteinase K market, by region, 2018 - 2030 (USD Million)
Table 7 U.S. proteinase K market, by form, 2018 - 2030 (USD Million)
Table 8 U.S. proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 9 U.S. proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. proteinase K market, by application, 2018 - 2030 (USD Million)
Table 11 Canada proteinase K market, by form, 2018 - 2030 (USD Million)
Table 12 Canada proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 13 Canada proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 14 Canada proteinase K market, by application, 2018 - 2030 (USD Million)
Table 15 Europe proteinase K market, by form, 2018 - 2030 (USD Million)
Table 16 Europe proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 17 Europe proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 18 Europe proteinase K market, by application, 2018 - 2030 (USD Million)
Table 19 Europe proteinase K market, by region, 2018 - 2030 (USD Million)
Table 20 UK proteinase K market, by form, 2018 - 2030 (USD Million)
Table 21 UK proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 22 UK proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 23 UK proteinase K market, by application, 2018 - 2030 (USD Million)
Table 24 Germany proteinase K market, by form, 2018 - 2030 (USD Million)
Table 25 Germany proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 26 Germany proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 27 Germany proteinase K market, by application, 2018 - 2030 (USD Million)
Table 28 France proteinase K market, by form, 2018 - 2030 (USD Million)
Table 29 France proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 30 France proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 31 France proteinase K market, by application, 2018 - 2030 (USD Million)
Table 32 Italy proteinase K market, by form, 2018 - 2030 (USD Million)
Table 33 Italy proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 34 Italy proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 35 Italy proteinase K market, by application, 2018 - 2030 (USD Million)
Table 36 Spain proteinase K market, by form, 2018 - 2030 (USD Million)
Table 37 Spain proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 38 Spain proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 39 Spain proteinase K market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark proteinase K market, by form, 2018 - 2030 (USD Million)
Table 41 Denmark proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 42 Denmark proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 43 Denmark proteinase K market, by application, 2018 - 2030 (USD Million)
Table 44 Sweden proteinase K market, by form, 2018 - 2030 (USD Million)
Table 45 Sweden proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 46 Sweden proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 47 Sweden proteinase K market, by application, 2018 - 2030 (USD Million)
Table 48 Norway proteinase K market, by form, 2018 - 2030 (USD Million)
Table 49 Norway proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 50 Norway proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 51 Norway proteinase K market, by application, 2018 - 2030 (USD Million)
Table 52 Asia Pacific proteinase K market, by form, 2018 - 2030 (USD Million)
Table 53 Asia Pacific proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 54 Asia Pacific proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 55 Asia Pacific proteinase K market, by application, 2018 - 2030 (USD Million)
Table 56 Asia Pacific proteinase K market, by region, 2018 - 2030 (USD Million)
Table 57 Japan proteinase K market, by form, 2018 - 2030 (USD Million)
Table 58 Japan proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 59 Japan proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 60 Japan proteinase K market, by application, 2018 - 2030 (USD Million)
Table 61 China proteinase K market, by form, 2018 - 2030 (USD Million)
Table 62 China proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 63 China proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 64 China proteinase K market, by application, 2018 - 2030 (USD Million)
Table 65 India proteinase K market, by form, 2018 - 2030 (USD Million)
Table 66 India proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 67 India proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 68 India proteinase K market, by application, 2018 - 2030 (USD Million)
Table 69 Australia proteinase K market, by form, 2018 - 2030 (USD Million)
Table 70 Australia proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 71 Australia proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 72 Australia proteinase K market, by application, 2018 - 2030 (USD Million)
Table 73 Thailand proteinase K market, by form, 2018 - 2030 (USD Million)
Table 74 Thailand proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 75 Thailand proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 76 Thailand proteinase K market, by application, 2018 - 2030 (USD Million)
Table 77 South Korea proteinase K market, by form, 2018 - 2030 (USD Million)
Table 78 South Korea proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 79 South Korea proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 80 South Korea proteinase K market, by application, 2018 - 2030 (USD Million)
Table 81 Latin America proteinase K market, by form, 2018 - 2030 (USD Million)
Table 82 Latin America proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 83 Latin America proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 84 Latin America proteinase K market, by application, 2018 - 2030 (USD Million)
Table 85 Latin America proteinase K market, by region, 2018 - 2030 (USD Million)
Table 86 Brazil proteinase K market, by form, 2018 - 2030 (USD Million)
Table 87 Brazil proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 88 Brazil proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 89 Brazil proteinase K market, by application, 2018 - 2030 (USD Million)
Table 90 Mexico proteinase K market, by form, 2018 - 2030 (USD Million)
Table 91 Mexico proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 92 Mexico proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 93 Mexico proteinase K market, by application, 2018 - 2030 (USD Million)
Table 94 Argentina proteinase K market, by form, 2018 - 2030 (USD Million)
Table 95 Argentina proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 96 Argentina proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 97 Argentina proteinase K market, by application, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa proteinase K market, by form, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa proteinase K market, by application, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa proteinase K market, by region, 2018 - 2030 (USD Million)
Table 103 South Africa proteinase K market, by form, 2018 - 2030 (USD Million)
Table 104 South Africa proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 105 South Africa proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 106 South Africa proteinase K market, by application, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia proteinase K market, by form, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia proteinase K market, by application, 2018 - 2030 (USD Million)
Table 111 UAE proteinase K market, by form, 2018 - 2030 (USD Million)
Table 112 UAE proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 113 UAE proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 114 UAE proteinase K market, by application, 2018 - 2030 (USD Million)
Table 115 Kuwait proteinase K market, by form, 2018 - 2030 (USD Million)
Table 116 Kuwait proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 117 Kuwait proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 118 Kuwait proteinase K market, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Proteinase K: Market outlook
Fig. 9 Proteinase K: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Proteinase K market driver impact
Fig. 15 Proteinase K market restraint impact
Fig. 16 Proteinase K market strategic initiatives analysis
Fig. 17 Proteinase K market: Form movement analysis
Fig. 18 Proteinase K market: Form outlook and key takeaways
Fig. 19 Powder market estimates and forecasts, 2018 - 2030
Fig. 20 Liquid market estimates and forecasts, 2018 - 2030
Fig. 21 Proteinase K market: Therapeutic area movement analysis
Fig. 22 Proteinase K market: Therapeutic area outlook and key takeaways
Fig. 23 Infectious diseases market estimates and forecasts, 2018 - 2030
Fig. 24 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 25 Oncology market estimates and forecasts, 2018 - 2030
Fig. 26 Cardiology market estimates and forecasts, 2018 - 2030
Fig. 27 Nephrology market estimates and forecasts, 2018 - 2030
Fig. 28 Autoimmune diseases market estimates and forecasts, 2018 - 2030
Fig. 29 Neurology market estimates and forecasts, 2018 - 2030
Fig. 30 Others market estimates and forecasts, 2018 - 2030
Fig. 31 Proteinase K market: Application movement analysis
Fig. 32 Proteinase K market: Application outlook and key takeaways
Fig. 33 Isolation and purification of genomic DNA & RNA market estimates and forecasts, 2018 - 2030
Fig. 34 In situ hybridization market estimates and forecasts, 2018 - 2030
Fig. 35 Mitochondria isolation market estimates and forecasts, 2018 - 2030
Fig. 36 Proteinase K market: End use movement analysis
Fig. 37 Proteinase K market: End use outlook and key takeaways
Fig. 38 Contract research organization market estimates and forecasts, 2018 - 2030
Fig. 39 Academic institutes market estimates and forecasts, 2018 - 2030
Fig. 40 Biotechnology companies market estimates and forecasts, 2018 - 2030
Fig. 41 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
Fig. 42 Global proteinase K market: Regional movement analysis
Fig. 43 Global proteinase K market: Regional outlook and key takeaways
Fig. 44 North America market estimates and forecasts, 2018 - 2030
Fig. 45 U.S. market estimates and forecasts, 2018 - 2030
Fig. 46 Canada market estimates and forecasts, 2018 - 2030
Fig. 47 Europe market estimates and forecasts, 2018 - 2030
Fig. 48 UK market estimates and forecasts, 2018 - 2030
Fig. 49 Germany market estimates and forecasts, 2018 - 2030
Fig. 50 France market estimates and forecasts, 2018 - 2030
Fig. 51 Italy market estimates and forecasts, 2018 - 2030
Fig. 52 Spain market estimates and forecasts, 2018 - 2030
Fig. 53 Denmark market estimates and forecasts, 2018 - 2030
Fig. 54 Sweden market estimates and forecasts, 2018 - 2030
Fig. 55 Norway market estimates and forecasts, 2018 - 2030
Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 57 Japan market estimates and forecasts, 2018 - 2030
Fig. 58 China market estimates and forecasts, 2018 - 2030
Fig. 59 India market estimates and forecasts, 2018 - 2030
Fig. 60 Australia market estimates and forecasts, 2018 - 2030
Fig. 61 Thailand market estimates and forecasts, 2018 - 2030
Fig. 62 South Korea market estimates and forecasts, 2018 - 2030
Fig. 63 Latin America market estimates and forecasts, 2018 - 2030
Fig. 64 Brazil market estimates and forecasts, 2018 - 2030
Fig. 65 Mexico market estimates and forecasts, 2018 - 2030
Fig. 66 Argentina market estimates and forecasts, 2018 - 2030
Fig. 67 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 68 South Africa market estimates and forecasts, 2018 - 2030
Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 70 UAE market estimates and forecasts, 2018 - 2030
Fig. 71 Kuwait market estimates and forecasts, 2018 - 2030

Product Code: GVR-4-68039-172-8

Proteinase K Market Growth & Trends:

The global proteinase K market size is expected to reach USD 7.8 billion by 2030, registering a CAGR of 8.7% during the forecast period, according to a new report by Grand View Research, Inc.. The market growth is fueled by a broad range of applications in molecular diagnostic techniques and their associated enzymes for IVD. Proteinase K can be utilized as a supplement in PCR and NGS. Increasing applications of NGS in personalized medicine along with various clinically developed therapies are likely to favor the market for proteinase K. Gene expression profiling and targeted panels via qPCR remain the two most frequent uses for NGS sequences in a pathology lab. In addition, a decline in the price of NGS sequencing has expanded the use of NSC technologies. Therefore, the growing demand for NGS diagnostic techniques is expected to boost the market growth.

In addition, the rising adoption of cell separation procedures is one of the major factors contributing to the market growth. Companies have initiated building sustainable technologies to gain a competitive edge in the market. For instance, in April 2022, Levitas Bio introduced the next generation of its existing platform for cell separation. The new version is expected to assist researchers in scaling their experiments up to 16X and process around 40 million cells per run.

Moreover, the usage of POC-based diagnostics is increasing significantly globally. Public awareness campaigns aimed at identifying the symptoms of infectious diseases and ways to prevent them play an important role in controlling disease transmission. Thus, increased patient attention has led to a rise in demand for POC. For instance, in May 2020, a study on POC testing for COVID-19 through Specific High Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK) diagnostics was published. The researchers used QuickExtract by Lucigen, which contains Proteinase K. Thus, the growing demand for POC diagnostics and the utility of proteinase K in POC diagnostic tests are expected to fuel market growth.

Furthermore, growing applications of proteinase K in molecular biology and other fields are expected to create lucrative opportunities in the near future. Proteinase K is used in the food and beverage industry to maintain quality standards. Food manufacturers work to maintain the quality of raw materials used for manufacturing. In addition, proteinase K is used for cell lysis during DNA extraction from processed foods. The enzyme also finds application in a wide range of molecular biology assays. Hence, such applications of proteinase K are anticipated to drive the market during the forecast period.

Proteinase K Market Report Highlights:

By form, the powder segment accounted for a dominant share in 2022. Advantages of powder form include long shelf-life, inexpensive shipment, and high stability. Thus, such advantages are expected to increase the adoption of powder
By therapeutic area, the infectious diseases segment captured the largest share in 2022. Presence of proteinase K in the rapid molecule testing along with increasing incidence of infectious diseases in low- to mid-income countries is anticipated to encourage players to develop products that are easy to operate in a low-resource setting. This is, in turn, accelerating the market growth
By application, the isolation and purification of genomic DNA and RNA segment held the largest share in 2022. With the emerging need for personalized treatment in cancer and rare diseases, the demand for DNA or RNA isolation is anticipated to witness upward trends and similar trends will be reflected in the market
By end-use, biotechnology companies held a leading revenue share in 2022. This is due to an increase in the application of In Situ Hybridization (ISH) techniques to support clinical and preclinical studies for biotechnology companies
North America occupied the largest market share in 2022 and is expected to maintain its lead over the forecast period owing to the high demand for proteinase K and the increasing prevalence of infectious diseases in the region
Asia Pacific is projected to grow considerably in the future owing to increasing applications of sequencing technology, coupled with various government initiatives to promote genomics research.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Form
- 1.1.2. Therapeutic area
- 1.1.3. End use
- 1.1.4. Application
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Form outlook
- 2.2.2. Therapeutic area outlook
- 2.2.3. End use outlook
- 2.2.4. Application outlook
- 2.2.5. Regional outlook
2.3. Competitive Insights

Chapter 3. Proteinase K Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
3.4. Proteinase K Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
  - 3.4.1.1. Supplier power
  - 3.4.1.2. Buyer power
  - 3.4.1.3. Substitution threat
  - 3.4.1.4. Threat of new entrant
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Technological landscape
  - 3.4.2.3. Economic landscape

Chapter 4. Proteinase K: Form Estimates & Trend Analysis

4.1. Proteinase K Market: Key Takeaways
4.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Powder
- 4.3.1. Powder market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Liquid
- 4.4.1. Liquid market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Proteinase K: Therapeutic Area Estimates & Trend Analysis

5.1. Proteinase K Market: Key Takeaways
5.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Infectious Diseases
- 5.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Diabetes
- 5.4.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Oncology
- 5.5.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Cardiology
- 5.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Nephrology
- 5.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Autoimmune Diseases
- 5.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Neurology
- 5.9.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Others
- 5.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Proteinase K: End Use Estimates & Trend Analysis

6.1. Proteinase K Market: Key Takeaways
6.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Isolation and Purification of Genomic DNA & RNA
- 6.3.1. Isolation and purification of genomic DNA & RNA market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. In Situ Hybridization
- 6.4.1. In situ hybridization market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Mitochondria Isolation
- 6.5.1. Mitochondria isolation market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Proteinase K: Application Estimates & Trend Analysis

7.1. Proteinase K Market: Key Takeaways
7.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Contract Research Organization
- 7.3.1. Contract research organization market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Academic Institutes
- 7.4.1. Academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Biotechnology Companies
- 7.5.1. Biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Diagnostic Laboratories
- 7.6.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Proteinase K Market: Regional Estimates & Trend Analysis

8.1. Regional Outlook
8.2. Proteinase K Market by Region: Key Takeaways
8.3. North America
- 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.3.2. U.S.
  - 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.3.3. Canada
  - 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.4. Europe
- 8.4.1. UK
  - 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.2. Germany
  - 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.3. France
  - 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.4. Italy
  - 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.5. Spain
  - 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.6. Denmark
  - 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.7. Sweden
  - 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.8. Norway
  - 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.5. Asia Pacific
- 8.5.1. Japan
  - 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.2. China
  - 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.3. India
  - 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.4. Australia
  - 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.5. Thailand
  - 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.6. South Korea
  - 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.6. Latin America
- 8.6.1. Brazil
  - 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.6.2. Mexico
  - 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.6.3. Argentina
  - 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
8.7. MEA
- 8.7.1. South Africa
  - 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.2. Saudi Arabia
  - 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.3. UAE
  - 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.4. Kuwait
  - 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
- 9.2.1. Merck KGaA
  - 9.2.1.1. Company overview
  - 9.2.1.2. Financial performance
  - 9.2.1.3. Product benchmarking
  - 9.2.1.4. Strategic initiatives
- 9.2.2. QIAGEN
  - 9.2.2.1. Company overview
  - 9.2.2.2. Financial performance
  - 9.2.2.3. Product benchmarking
  - 9.2.2.4. Strategic initiatives
- 9.2.3. Thermo Fisher Scientific, Inc.
  - 9.2.3.1. Company overview
  - 9.2.3.2. Financial performance
  - 9.2.3.3. Product benchmarking
  - 9.2.3.4. Strategic initiatives
- 9.2.4. F. Hoffmann-La Roche Ltd
  - 9.2.4.1. Company overview
  - 9.2.4.2. Financial performance
  - 9.2.4.3. Product benchmarking
  - 9.2.4.4. Strategic initiatives
- 9.2.5. Abcam plc.
  - 9.2.5.1. Company overview
  - 9.2.5.2. Financial performance
  - 9.2.5.3. Product benchmarking
  - 9.2.5.4. Strategic initiatives
- 9.2.6. Agilent Technologies, Inc.
  - 9.2.6.1. Company overview
  - 9.2.6.2. Financial performance
  - 9.2.6.3. Product benchmarking
  - 9.2.6.4. Strategic initiatives
- 9.2.7. Biocatalysts
  - 9.2.7.1. Company overview
  - 9.2.7.2. Financial performance
  - 9.2.7.3. Product benchmarking
  - 9.2.7.4. Strategic initiatives
- 9.2.8. Minerva Biolabs GmbH
  - 9.2.8.1. Company overview
  - 9.2.8.2. Financial performance
  - 9.2.8.3. Product benchmarking
  - 9.2.8.4. Strategic initiatives
- 9.2.9. Promega Corporation
  - 9.2.9.1. Company overview
  - 9.2.9.2. Financial performance
  - 9.2.9.3. Product benchmarking
  - 9.2.9.4. Strategic initiatives
- 9.2.10. Takara Bio Inc.
  - 9.2.10.1. Company overview
  - 9.2.10.2. Financial performance
  - 9.2.10.3. Product benchmarking
  - 9.2.10.4. Strategic initiatives
- 9.2.11. New England Biolabs
  - 9.2.11.1. Company overview
  - 9.2.11.2. Financial performance
  - 9.2.11.3. Product benchmarking
  - 9.2.11.4. Strategic initiatives
- 9.2.12. MP BIOMEDICALS.
  - 9.2.12.1. Company overview
  - 9.2.12.2. Financial performance
  - 9.2.12.3. Product benchmarking
  - 9.2.12.4. Strategic initiatives

プロテイナーゼKの市場規模、シェア、動向分析レポート：形態別、治療領域別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

Proteinase K Market Size, Share & Trends Analysis Report By Form (Powder, Liquid), By Therapeutic Area (Infectious Diseases, Neurology, Oncology, Cardiology), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

プロテイナーゼK市場の成長と動向：

プロテイナーゼK市場のハイライト

目次

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章プロテイナーゼK市場変数、動向、範囲

第4章プロテイナーゼK：形態別推定・動向分析

第5章プロテイナーゼK：治療領域別推定・動向分析

第6章プロテイナーゼK：最終用途別推定・動向分析

第7章プロテイナーゼK：用途別推定・動向分析

第8章プロテイナーゼK市場：地域別推定・動向分析

第9章競合情勢

List of Tables

List of Figures

Proteinase K Market Growth & Trends:

Proteinase K Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Proteinase K Market Variables, Trends & Scope

Chapter 4. Proteinase K: Form Estimates & Trend Analysis

Chapter 5. Proteinase K: Therapeutic Area Estimates & Trend Analysis

Chapter 6. Proteinase K: End Use Estimates & Trend Analysis

Chapter 7. Proteinase K: Application Estimates & Trend Analysis

Chapter 8. Proteinase K Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

プロテイナーゼKの市場規模、シェア、動向分析レポート：形態別、治療領域別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

Proteinase K Market Size, Share & Trends Analysis Report By Form (Powder, Liquid), By Therapeutic Area (Infectious Diseases, Neurology, Oncology, Cardiology), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

プロテイナーゼK市場の成長と動向：

プロテイナーゼK市場のハイライト

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 プロテイナーゼK市場変数、動向、範囲

第4章 プロテイナーゼK：形態別推定・動向分析

第5章 プロテイナーゼK：治療領域別推定・動向分析

第6章 プロテイナーゼK：最終用途別推定・動向分析

第7章 プロテイナーゼK：用途別推定・動向分析

第8章 プロテイナーゼK市場：地域別推定・動向分析

第9章 競合情勢

List of Tables

List of Figures

Proteinase K Market Growth & Trends:

Proteinase K Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Proteinase K Market Variables, Trends & Scope

Chapter 4. Proteinase K: Form Estimates & Trend Analysis

Chapter 5. Proteinase K: Therapeutic Area Estimates & Trend Analysis

Chapter 6. Proteinase K: End Use Estimates & Trend Analysis

Chapter 7. Proteinase K: Application Estimates & Trend Analysis

Chapter 8. Proteinase K Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

第1章調査手法と範囲

第2章エグゼクティブサマリー

第3章プロテイナーゼK市場変数、動向、範囲

第4章プロテイナーゼK：形態別推定・動向分析

第5章プロテイナーゼK：治療領域別推定・動向分析

第6章プロテイナーゼK：最終用途別推定・動向分析

第7章プロテイナーゼK：用途別推定・動向分析

第8章プロテイナーゼK市場：地域別推定・動向分析

第9章競合情勢